Said, half-life of new and existing protein drugs – Innovative Biopharmaceutical Company, PolyTherics collects about 2 million poundsSusan Searle, Imperial Innovations, said, Polytherics have considerable economic and technological progress over the couple of past years. To support to support the team, as the company embarks on the next phase of growth. .This information has been from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation They can view the entire Emperor Daily Health policy coverage from, search the archives and sign up for email for delivery at Imperial health news.